Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine

Systems and Synthetic Biology

Volumn 5, Issue 1, 2011, Pages 21-31

  Amidi, Maryam ^a   de Raad, Markus ^a   Crommelin, Daan J A ^a   Hennink, Wim E ^a   Mastrobattista, Enrico ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cell free protein synthesis; DNA vaccination; Synthetic biology; Vaccine

Indexed keywords

BACTERIA (MICROORGANISMS); MUS;

EID: 80052029345     PISSN: 18725325     EISSN: 18725333     Source Type: Journal    
DOI: 10.1007/s11693-010-9066-z     Document Type: Article

References (62)

1. Abdulhaqq SA, Weiner DB (2008) DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 42(1-3): 219-232. doi: 10. 1007/s12026-008-8076-3.
2. Amidi M, Pellikaan HC, Hirschberg H, de Boer AH, Crommelin DJ, Hennink WE, Kersten G, Jiskoot W (2007) Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Vaccine 25(37-38): 6818-6829.
3. Amidi M, de Raad M, de Graauw H, van Ditmarsch D, Hennink WE, Crommelin DJ, Mastrobattista E (2010) Optimization and quantification of protein synthesis inside liposomes. J Liposome Res 20(1): 73-83. doi: 10. 3109/08982100903402954.
4. Beebe ET, Makino SI, Nozawa A, Matsubara Y, Frederick RO, Primm JG, Goren MA, Fox BG (2010) Robotic large-scale application of wheat cell-free translation to structural studies including membrane proteins. N Biotechnol. doi: 10. 1016/j. nbt. 2010. 07. 003.
5. Berrier C, Park KH, Abes S, Bibonne A, Betton JM, Ghazi A (2004) Cell-free synthesis of a functional ion channel in the absence of a membrane and in the presence of detergent. Biochemistry 43(39): 12585-12591.
6. Bollag DM, Edelstein SJ (1991) Protein methods. Wiley-Liss Publications, New York.
7. Canton B, Labno A, Endy D (2008) Refinement and standardization of synthetic biological parts and devices. Nat Biotech 26(7): 787-793. doi: http://www. nature. com/nbt/journal/v26/n7/suppinfo/nbt1413_S1. html.
8. Coutelier JP, van der Logt JT, Heessen FW, Warnier G, van Snick J (1987) Igg2a restriction of murine antibodies elicited by viral infections. J Exp Med 165(1): 64-69.
9. DesRoches C, Blendon R, Benson J (2005) Americans' responses to the 2004 influenza vaccine shortage. Health Aff 24(3): 822.
10. Foged C, Brodin B, Frokjaer S, Sundblad A (2005) Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298(2): 315-322.
11. Gissmann L (2009) Hpv vaccines: preclinical development. Arch Med Res 40(6): 466-470.
12. Goren MA, Nozawa A, Makino S, Wrobel RL, Fox BG (2009) Cell-free translation of integral membrane proteins into unilamelar liposomes. Methods Enzymol 463: 647-673. doi: 10. 1016/S0076-6879(09)63037-8.
13. Henderson MP, Billen LP, Kim PK, Andrews DW (2007) Cell-free analysis of tail-anchor protein targeting to membranes. Methods 41(4): 427-438. doi: 10. 1016/j. ymeth. 2006. 07. 004.
14. Hinman AR, Orenstein WA, Santoli JM, Rodewald LE, Cochi SL (2006) Vaccine shortages: history, impact, and prospects for the future. Annu Rev Public Health 27: 235-259.
15. Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, Burk RD (2002) Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 186(6): 737-742. doi: 10. 1086/342972.
16. Hocart MJ, Mackenzie JS, Stewart GA (1989) The immunoglobulin g subclass responses of mice to influenza a virus: the effect of mouse strain, and the neutralizing abilities of individual protein a-purified subclass antibodies. J Gen Virol 70(Pt 9): 2439-2448.
17. Hovden AO, Cox RJ, Madhun A, Haaheim LR (2005) Two doses of parenterally administered split influenza virus vaccine elicited high serum igg concentrations which effectively limited viral shedding upon challenge in mice. Scand J Immunol 62(4): 342-352. doi: 10. 1111/j. 1365-3083. 2005. 01666. x.
18. Ishihara G, Goto M, Saeki M, Ito K, Hori T, Kigawa T, Shirouzu M, Yokoyama S (2005) Expression of g protein coupled receptors in a cell-free translational system using detergents and thioredoxin-fusion vectors. Protein Expr Purif 41(1): 27-37.
19. Ishikawa K, Sato K, Shima Y, Urabe I, Yomo T (2004) Expression of a cascading genetic network within liposomes. FEBS Lett 576(3): 387-390.
20. Jewett MC, Calhoun KA, Voloshin A, Wuu JJ, Swartz JR (2008) An integrated cell-free metabolic platform for protein production and synthetic biology. Mol Syst Biol 4: 220. doi: 10. 1038/msb. 2008. 57.
21. Junge F, Haberstock S, Roos C, Stefer S, Proverbio D, Dotsch V, Bernhard F (2010) Advances in cell-free protein synthesis for the functional and structural analysis of membrane proteins. N Biotechnol. doi: 10. 1016/j. nbt. 2010. 07. 002.
22. Kanter G, Yang J, Voloshin A, Levy S, Swartz JR, Levy R (2007) Cell-free production of scfv fusion proteins: an efficient approach for personalized lymphoma vaccines. Blood 109(8): 3393-3399. doi: 10. 1182/blood-2006-07-030593.
23. Kita H, Matsuura T, Sunami T, Hosoda K, Ichihashi N, Tsukada K, Urabe I, Yomo T (2008) Replication of genetic information with self-encoded replicase in liposomes. Chembiochem 9(15): 2403-2410. doi: 10. 1002/cbic. 200800360.
24. Klinman DM, Klaschik S, Sato T, Tross D (2009) Cpg oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv Drug Deliv Rev 61(3): 248-255.
25. Knight T (2003) Idempotent vector design for standard assembly of biobricks. MIT Artificial Intelligence Laboratory; MIT Synthetic Biology Working Group. http://hdl. handle. net/1721. 1/21168.
26. Kohyama S, Ohno S, Suda T, Taneichi M, Yokoyama S, Mori M, Kobayashi A, Hayashi H, Uchida T, Matsui M (2009) Efficient induction of cytotoxic t lymphocytes specific for severe acute respiratory syndrome (sars)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a. Antiviral Res 84(2): 168-177.
27. Kuruma Y, Suzuki T, Ueda T (2010) Production of multi-subunit complexes on liposome through an e. Coli cell-free expression system. Methods Mol Biol 607: 161-171. doi: 10. 1007/978-1-60327-331-2_14.
28. Liu MA, Ulmer JB (2005) Human clinical trials of plasmid DNA vaccines. Adv Genet 55: 25-40. doi: 10. 1016/S0065-2660(05)55002-8.
29. Lu S (2008) Immunogenicity of DNA vaccines in humans: it takes two to tango. Hum Vaccin 4(6): 449-452.
30. Mastrobattista E, Taly V, Chanudet E, Treacy P, Kelly BT, Griffiths AD (2005) High-throughput screening of enzyme libraries: in vitro evolution of a beta-galactosidase by fluorescence-activated sorting of double emulsions. Chem Biol 12(12): 1291-1300.
31. Matsui M, Kohyama S, Suda T, Yokoyama S, Mori M, Kobayashi A, Taneichi M, Uchida T (2010) A ctl-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in hla-a*0201 transgenic mice. Biochem Biophys Res Commun 391(3): 1494-1499.
32. Montefiori DC, Mascola JR (2009) Neutralizing antibodies against hiv-1: Can we elicit them with vaccines and how much do we need? Curr Opin HIV AIDS 4(5): 347-351. doi: 310. 1097/COH. 1090b1013e32832f32834a32834d.
33. Montefiori D, Sattentau Q, Flores J, Esparza J, Mascola J, Va WGCGH (2007) Antibody-based hiv-1 vaccines: recent developments and future directions. PLoS Med 4(12): 1867-1871. doi: 10. 1371/journal. pmed. 0040348.
34. Moritani Y, Nomura SI, Morita I, Akiyoshi K (2010) Direct integration of cell-free-synthesized connexin-43 into liposomes and hemichannel formation. FEBS J. doi: 10. 1111/j. 1742-4658. 2010. 07736. x.
35. Murtas G, Kuruma Y, Bianchini P, Diaspro A, Luisi PL (2007) Protein synthesis in liposomes with a minimal set of enzymes. Biochem Biophys Res Commun 363(1): 12-17. doi: 10. 1016/j. bbrc. 2007. 07. 201.
36. Naito S, Horino A, Nakayama M, Nakano Y, Nagai T, Mizuguchi J, Komuro K, Uchida T (1996) Ovalbumin-liposome conjugate induces igg but not ige antibody production. Int Arch Allergy Immunol 109(3): 223-228.
37. Nozawa A, Nanamiya H, Tozawa Y (2010) Production of membrane proteins through the wheat-germ cell-free technology. Methods Mol Biol 607: 213-218. doi: 10. 1007/978-1-60327-331-2_17.
38. Oberholzer T, Nierhaus KH, Luisi PL (1999) Protein expression in liposomes. Biochem Biophys Res Commun 261(2): 238-241.
39. Ohno S, Kohyama S, Taneichi M, Moriya O, Hayashi H, Oda H, Mori M, Kobayashi A, Akatsuka T, Uchida T, Matsui M (2009) Synthetic peptides coupled to the surface of liposomes effectively induce sars coronavirus-specific cytotoxic t lymphocytes and viral clearance in hla-a*0201 transgenic mice. Vaccine 27(29): 3912-3920.
40. Poland G, Ovsyannikova I, Jacobson R (2008) Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 8(11): 1659-1667.
41. Reckel S, Sobhanifar S, Durst F, Lohr F, Shirokov VA, Dotsch V, Bernhard F (2010) Strategies for the cell-free expression of membrane proteins. Methods Mol Biol 607: 187-212. doi: 10. 1007/978-1-60327-331-2_16.
42. Rosenberg SA, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE (2003) Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen. Hum Gene Ther 14(8): 709-714. doi: 10. 1089/104303403765255110.
43. Sattentau Q (2008) Correlates of antibody-mediated protection against hiv infection. Curr Opin HIV AIDS 3(3): 368-374. doi: 10. 1097/COH. 0b013e3282f9ae79.
44. Shimizu Y, Inoue A, Tomari Y, Suzuki T, Yokogawa T, Nishikawa K, Ueda T (2001) Cell-free translation reconstituted with purified components. Nat Biotech 19 (8): 751-755. doi: http://www. nature. com/nbt/journal/v19/n8/suppinfo/nbt0801_751_S1. html.
45. Simpson ML (2006) Cell-free synthetic biology: a bottom-up approach to discovery by design. Mol Syst Biol 2. doi: 6910. 1038/msb4100104.
46. Smith LA (2009) Botulism and vaccines for its prevention. Vaccine 27(Suppl 4): D33-D39.
47. Sunami T, Sato K, Matsuura T, Tsukada K, Urabe I, Yomo T (2006) Femtoliter compartment in liposomes for in vitro selection of proteins. Anal Biochem 357(1): 128-136. doi: 10. 1016/j. ab. 2006. 06. 040.
48. Sunami T, Matsuura T, Suzuki H, Yomo T (2010) Synthesis of functional proteins within liposomes. Methods Mol Biol 607: 243-256. doi: 10. 1007/978-1-60327-331-2_20.
49. Tabata Y, Inoue Y, Ikada Y (1996) Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 14(17-18): 1677-1685.
50. Takagi A, Matsui M, Ohno S, Duan HY, Moriya O, Kobayashi N, Oda H, Mori M, Kobayashi A, Taneichi M, Uchida T, Akatsuka T (2009) Highly efficient antiviral cd8(+) t-cell induction by peptides coupled to the surfaces of liposomes. Clin Vaccine Immunol 16(10): 1383-1392. doi: 10. 1128/Cvi. 00116-09.
51. Taneichi M, Ishida H, Kajino K, Ogasawara K, Tanaka Y, Kasai M, Mori M, Nishida M, Yamamura H, Mizuguchi J, Uchida T (2006a) Antigen chemically coupled to the surface of liposomes are cross-presented to cd8 + t cells and induce potent antitumor immunity. J Immunol 177(4): 2324-2330.
52. Taneichi M, Tanaka Y, Kasai M, Mori M, Nishida M, Yamamura H, Mizuguchi J, Uchida T (2006b) Induction of differential t-cell epitope by plain- and liposome-coupled antigen. Bioconj Chem 17(4): 899-904. doi: 10. 1021/bc060024g.
53. Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, Pardoll D, Wu TC (2009) A phase i trial of a human papillomavirus DNA vaccine for hpv16 + cervical intraepithelial neoplasia 2/3. Clin Cancer Res 15(1): 361-367. doi: 10. 1158/1078-0432. CCR-08-1725.
54. Tsuboi T, Takeo S, Iriko H, Jin L, Tsuchimochi M, Matsuda S, Han ET, Otsuki H, Kaneko O, Sattabongkot J, Udomsangpetch R, Sawasaki T, Torii M, Endo Y (2008) Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun 76(4): 1702-1708. doi: 10. 1128/IAI. 01539-07.
55. Tsuboi T, Takeo S, Arumugam TU, Otsuki H, Torii M (2010a) The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery. Acta Trop 114(3): 171-176. doi: 10. 1016/j. actatropica. 2009. 10. 024.
56. Tsuboi T, Takeo S, Sawasaki T, Torii M, Endo Y (2010b) An efficient approach to the production of vaccines against the malaria parasite. Methods Mol Biol 607: 73-83. doi: 10. 1007/978-1-60327-331-2_8.
57. Uchida T, Taneichi M (2008) Clinical application of surface-linked liposomal antigens. Mini Rev Med Chem 8(2): 184-192.
58. Ulmer JB, Valley U, Rappuoli R (2006) Vaccine manufacturing: challenges and solutions. Nat Biotechnol 24(11): 1377-1383. doi: 10. 1038/nbt1261.
59. Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M (2006) Pathogen recognition and development of particulate vaccines: does size matter? Methods 40(1): 1-9.
60. Yamaji K, Kanai T, Nomura SM, Akiyoshi K, Negishi M, Chen Y, Atomi H, Yoshikawa K, Imanaka T (2009) Protein synthesis in giant liposomes using the in vitro translation system of thermococcus kodakaraensis. IEEE Trans Nanobioscience 8(4): 325-331. doi: 10. 1109/TNB. 2009. 2035278.
61. Yoshida M, Babensee JE (2006) Molecular aspects of microparticle phagocytosis by dendritic cells. J Biomater Sci Polym Ed 17(8): 893-907.
62. Zichel R, Mimran A, Keren A, Barnea A, Steinberger-Levy I, Marcus D, Turgeman A, Reuveny S (2010) Efficacy of a potential trivalent vaccine based on hc fragments of botulinum toxins a, b, and e produced in a cell-free expression system. Clin Vaccine Immunol 17(5): 784-792. doi: 10. 1128/CVI. 00496-09.